| Literature DB >> 33280257 |
Yasuhisa Ando1, Keiichi Okano1, Hiroshi Yasumatsu2, Toshimasa Okada3, Kimiyoshi Mizunuma4, Minoru Takada5, Shinjiro Kobayashi6, Keisuke Suzuki7, Nobuya Kitamura8, Minoru Oshima1, Hironobu Suto1, Miyatake Nobuyuki9, Yasuyuki Suzuki1.
Abstract
BACKGROUND: Pancreatic trauma is reportedly associated with high morbidity and mortality. Main pancreatic duct (MPD) injury is critical for treatment.Entities:
Keywords: endoscopic retrograde pancreatography; main pancreatic duct injury; management; nationwide survey; pancreatic trauma
Mesh:
Year: 2021 PMID: 33280257 PMCID: PMC7986433 DOI: 10.1002/jhbp.877
Source DB: PubMed Journal: J Hepatobiliary Pancreat Sci ISSN: 1868-6974 Impact factor: 7.027
Demographics and clinical characteristics of patients with or without main pancreatic duct (MPD) injury (number [%] or value)
| Variables |
Overall n = 163 |
MPD intact n = 99 |
MPD injured n = 64 | Univariate analysis | Multivariate analysis |
|---|---|---|---|---|---|
| Gender | |||||
| Male/Female | 109(67)/54 (33) | 62 (63)/37 (37) | 47 (73)/17 (27) | 0.152 | |
| Age (y) | 42.7 ± 1.8 | 45.6 ± 2.3 | 38.3 ± 2.8 | 0.045 | 0.388 |
| Cause of trauma | |||||
| Traffic accident | 90 (55) | 55 (56) | 35 (55) | 0.913 | |
| Non–traffic accident | 73 (45) | 44 (44) | 29 (45) | ||
| Injury type | |||||
| Blunt | 140 (86) | 78 (79) | 62 (97) | 0.001 | 0.007 |
| Penetrating | 23 (14) | 21 (21) | 2 (3) | ||
| Intraabdominal injury | |||||
| Pancreas only | 55 (34) | 23 (23) | 32 (50) | <0.001 | 0.013 |
| Pancreas injury location | |||||
| Head | 66 (40) | 47 (47) | 19 (30) | 0.033 | |
| Body or tail | 97 (60) | 52 (53) | 45 (70) | ||
| Injury Severity Score (ISS) | 15.8 ± 0.9 | 16.2 ± 1.1 | 15.3 ± 1.4 | 0.613 | 0.998 |
| Revised Trauma Score (RTS) | 7.3 ± 0.1 | 7.3 ± 0.1 | 7.4 ± 0.1 | 0.655 | |
Frequency (%) for categorical variables.
Mean (standard deviation [SD]) for continuous variables.
FIGURE 1Laboratory values within 48 h of injury between the groups with and without MPD injury (n = 144). Serum amylase levels in the vertical axis are displayed using a logarithmic scale. WBC (/μL; 13 491 ± 609 vs 13 328 ± 749, P = .865). CRP (mg/dL; 0.56 ± 0.5 vs 2.44 ± 51, P = .010). Amylase (U/L; 220.0 ± 51 vs 506.1 ± 64, P < .001). CRP, C‐reactive protein; MPD, main pancreatic duct; WBC, white blood cell. One‐way analysis of variance
Treatment and outcomes of patients with or without main pancreatic duct (MPD) injury (number (%) or value)
| Variables | Overall n = 163 | MPD intact n = 99 | MPD injured n = 64 |
|
|---|---|---|---|---|
|
| ||||
| Rate of ERP | 41 (25) | 14 (14) | 27 (42) | <.001 |
| Initial treatment strategy | ||||
| Non‐operative management (NOM) | 58 (36) | 47 (47) | 11 (17) | <.001 |
| Operative management (OM) | 105 (64) | 52 (53) | 53 (83) | |
| Outcomes | ||||
| Complications | 66 (40) | 28 (28) | 38 (59) | <.001 |
| NOM | 17 (29) | 8 (17) | 9 (82) | <.001 |
| OM | 49 (47) | 20 (38) | 29 (55) | .095 |
| Hospital stay (d) | 43.2 ± 3.6 | 37.6 ± 4.6 | 51.8 ± 5.7 | .055 |
| Mortality | 8 (5) | 6 (6) | 2 (3) | .397 |
Frequency (%) for categorical variables.
Mean (standard deviation [SD]) for continuous variables.
Abbreviation: ERP, endoscopic retrograde pancreatography.
Clavien–Dindo classification of grade IIIa or higher.
Accuracy of imaging modalities to detect MPD injury and diagnose the type of injury in grade III patients
| Imaging modality | n (%) | CT | ERP | MRP | |||
|---|---|---|---|---|---|---|---|
| Number of patients | n = 84 | 80 (95) | 35 (42) | 11 (13) | |||
| MPD injury | |||||||
| Grade | Positive | Negative | Positive | Negative | Positive | Negative | |
| IIIa | 1 | 17 | 0 | 8 | 0 | 1 | |
| IIIb | 50 | 12 | 26 | 1 | 8 | 2 | |
| Sensitivity | 0.81 | 0.96 | 0.8 | ||||
| Specificity | 0.99 | 1.0 | 0.89 | ||||
Abbreviations: MPD, Main pancreatic duct; CT, Computed tomography; ERP, Endoscopic retrograde pancreatography; MRP, Magnetic resonance pancreatography.
Demographics and clinical characteristics of main pancreatic duct injured patients initially treated with operative and nonoperative management
| Variables |
Nonoperative management n = 11 |
Operative management n = 53 |
|
|---|---|---|---|
|
| |||
| Age (y) | 49.5 ± 6.9 | 35.9 ± 3.1 | .079 |
| Injury type | |||
| Blunt | 11 (100) | 51 (96) | .513 |
| Penetrating | 0 (0) | 2 (4) | |
| Intraabdominal injury | |||
| Pancreas only | 5 (45) | 27 (51) | .740 |
| Pancreas injury location | |||
| Head | 4 (36) | 15 (28) | .594 |
| Body or tail | 7 (64) | 38 (72) | |
| Rate of comorbidities | 5 (45) | 10 (23) | .058 |
| Injury Severity Score (ISS) | 14.7 ± 2.5 | 15.4 ± 1.1 | .814 |
| Laboratory values | |||
| WBC (/μL) | 12,825 ± 1634 | 13,577 ± 744 | .677 |
| CRP (mg/dL) | 2.9 ± 2.2 | 3.2 ± 1.0 | .895 |
| Amylase (U/L) | 562.8 ± 205.7 | 482.6 ± 91.1 | .723 |
|
| |||
| Rate of ERP | 6 (55) | 22 (42) | .428 |
|
| |||
| Complications | 9 (82) | 29 (55) | .096 |
| Pseudocyst | 4 (36) | 6 (11) | |
| Pancreatic fistula | 4 (36) | 22 (42) | |
| Abscess | 2 (18) | 10 (19) | |
| Peritonitis | 2 (18) | 2 (4) | |
| Conversion to surgery | 5 (45) | ||
| Hospital stay (d) | 77.3 ± 13.0 | 47.2 ± 5.7 | .038 |
| Mortality | 0 (0) | 2 (4) | .513 |
Frequency (%) for categorical variables.
Mean (standard deviation [SD]) for continuous variables.
Abbreviations: CRP, C‐reactive protein; ERP, endoscopic retrograde pancreatography; WBC, white blood cell.
Clavien–Dindo classification of grade IIIa or higher.
Overlapping distribution.
Individual characteristics and outcomes of main pancreatic duct (MPD) injured patients initially treated with nonoperative management
| Case | Age/Gender | Pancreas injury (location) | Type of MPD injury (CT/ERP/MRP) | ERP | Initial treatment | Second treatment | Hospital stay (days) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Treatment modality | Post‐traumatic hours | Outcome and complications | Conversion modality | Post‐traumatic days | Outcome and complications | ||||||
| 1 | 77/F | Body/Tail | Partial (CT) | No | Drainage | 2 | Recovered | None | None | None | 235 |
| 2 | 61/M | Body | Complete (CT/ERP) | Yes | Drainage | 1 | Pseudocyst | Operation (DP) | 18 | Pancreatic fistula | 119 |
| 3 | 86/M | Body | Partial (CT/MRP) | No | Drainage | 792 | Pseudocyst | ENPD | unknown | Recovered | 20 |
| 4 | 73/M | Tail | Partial (CT) | No | Drainage | 1 | Abscess | ENPD | >30 | Recovered | 185 |
| Pancreatic fistula | |||||||||||
| 5 | 60/M | Body | Partial (CT) | No | Drainage | 144 | Pancreatic fistula | Operation (DP) | 32 | Pancreatic fistula | 87 |
| 6 | 24/M | Head | Complete (CT/ERP) | Yes | EPS | 10 | Recovered | None | None | None | 34 |
| 7 | 8/M | Head / Body | Complete (CT/ERP) | Yes | EPS | 5 | Peritonitis | Operation (PD) | 2 | Bile leakage | 26 |
| 8 | 71/M | Head | Partial (CT/ERP) | Yes | EPS | 4 | Peritonitis | Operation (Operative drainage) | 2.5 | Intestinal perforation | 34 |
| 9 | 57/M | Tail | Partial (CT/ERP) | Yes | EPS | 1.5 | Pseudocyst | Drainage | 4 | Recovered | 105 |
| Pancreatic fistula | |||||||||||
| Abscess | |||||||||||
| 10 | 11/M | Head | Complete (CT/ERP/MRP) | Yes | EPS | 30 | Pseudocyst | None | None | None | 82 |
| 11 | 16/M | Body | Complete (CT/ERP/MRP) | No | Octreotide | 1 | Pancreatic fistula | Operation (L&W) | 24 | Recovered | 31 |
Abbreviations: CT, computed tomography; DP, distal pancreatectomy; Drainage, percutaneous drainage; ENPD, endoscopic nasopancreatic drainage; EPS, endoscopic pancreatic stenting; ERP, endoscopic retrograde pancreatography; L&W, Letton–Wilson's procedure; MRP, magnetic resonance pancreatography; PD, pancreatoduodenectomy.
Clinical characteristics and outcomes of 53 main pancreatic duct injured patients initially treated with operative management
| Operation | Patient number (%) | Age (year) | Operation time (min) | Amount of bleeding (mL) | POPF ≧ grade B n (%) | Postoperative complication | Hospital stay (days) | Mortality n (%) |
|---|---|---|---|---|---|---|---|---|
| Pancreatic resection | 48 (90) | 29 [4‐83] | 258 [85‐690] | 1,090 [0‐5831] | 19 (40) | 30 (63) | 37 [2‐130] | 2 (4) |
| Pancreaticoduodenectomy | 10 (19) | 29.5 [16‐77] | 347.5 [85‐550] | 2,525.5 [563‐4300] | 4 (40) | 5 (50) | 43.5 [25‐126] | 0 (0) |
| Distal pancreatectomy | 14 (26) | 42[11‐78] | 176.5 [85‐360] | 1908[100‐5831] | 6 (43) | 9 (64) | 35[2‐97] | 2 (4) |
| Warshaw procedure | 9 (17) | 22 | 180 [120‐348] | 555.5 [70‐1340] | 5 (56) | 7 (78) | 30 [7‐126] | 0 (0) |
| Pancreas‐sparing surgery | ||||||||
| Letton–Wilson's procedure | 11 (20) | 18 | 280 [181‐690] | 514 | 3 (27) | 7 (64) | 31 [7‐55] | 0 (0) |
| Bracy procedure | 4 (8) | 31 [24‐83] | 398.5 [300‐526] | 1584.5 [400‐2400] | 1 (25) | 2 (50) | 37 [32‐52] | 0 (0) |
| No pancreatic resection | 5 (10) | 32 [19‐57] | 240 [190‐418] | 850 [520‐11673] | 4 (80) | 5 (100) | 65 | 0 (0) |
| Drainage | 2 (4) | 34.5 [19‐50] | 304 [190‐418] | 1,075 [850‐1300] | 1 (50) | 2 (100) | 119.5 [64‐175] | 0 (0) |
| Pancreatic suture repair | 3 (6) | 32 [28‐57] | 240 [221‐265] | 700 [520‐11673] | 3 (100) | 3 (100) | 65 [30‐117] | 0 (0) |
Frequency (%) for categorical variables.
Median (range) for other continuous variables.
Clavien–Dindo classification of grade IIIa or higher.
P = .003 vs Pancreatic resection.
P = .038 vs Pancreaticoduodenectomy.
P = .010 vs Pancreaticoduodenectomy.
P = .018 vs Distal pancreatectomy.